Zigang Dong

36.3k total citations · 7 hit papers
578 papers, 28.0k citations indexed

About

Zigang Dong is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Zigang Dong has authored 578 papers receiving a total of 28.0k indexed citations (citations by other indexed papers that have themselves been cited), including 406 papers in Molecular Biology, 165 papers in Oncology and 90 papers in Cancer Research. Recurrent topics in Zigang Dong's work include Cancer-related Molecular Pathways (76 papers), Melanoma and MAPK Pathways (60 papers) and Genomics, phytochemicals, and oxidative stress (42 papers). Zigang Dong is often cited by papers focused on Cancer-related Molecular Pathways (76 papers), Melanoma and MAPK Pathways (60 papers) and Genomics, phytochemicals, and oxidative stress (42 papers). Zigang Dong collaborates with scholars based in United States, China and South Korea. Zigang Dong's co-authors include Ann M. Bode, Weiya Ma, Chuanshu Huang, Ki Won Lee, Yong‐Yeon Cho, Kangdong Liu, Mee‐Hyun Lee, Qing‐Bai She, Wei-Ya Ma and Nanyue Chen and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Zigang Dong

570 papers receiving 27.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Post-translational modification of p53 in tumorigenesis

2004 990 citations Ann M. Bode, Zigang Dong profile →
AKT as a Therapeutic Target for Cancer

2019 617 citations Ann M. Bode, Zigang Dong et al. Cancer Research profile →
Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy

2021 340 citations Ruijuan Du, Chuntian Huang et al. profile →
Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery

2024 112 citations Zigang Dong, Kangdong Liu et al. profile →
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches

2024 92 citations Xuechao Jia, Zigang Dong et al. profile →
Integrins in cancer: Emerging mechanisms and therapeutic opportunities

2023 88 citations Fangfang Liu, Zigang Dong et al. profile →
Inflammation in cancer: therapeutic opportunities from new insights

2025 26 citations Zigang Dong et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zigang Dong United States	88	17.1k	5.7k	4.4k	3.1k	2.4k	578	28.0k
Ann M. Bode United States	77	12.4k 0.7×	4.1k 0.7×	3.3k 0.7×	2.4k 0.8×	1.6k 0.7×	422	21.1k
Nihal Ahmad United States	71	8.5k 0.5×	3.1k 0.5×	2.2k 0.5×	4.9k 1.6×	1.5k 0.6×	240	22.9k
Thomas W. Kensler United States	104	28.8k 1.7×	2.5k 0.4×	4.7k 1.1×	2.2k 0.7×	1.9k 0.8×	407	42.4k
Yung Hyun Choi South Korea	73	12.5k 0.7×	2.5k 0.4×	2.9k 0.7×	1.6k 0.5×	1.2k 0.5×	929	24.6k
Hong Zhang China	73	12.5k 0.7×	3.7k 0.6×	2.7k 0.6×	1.4k 0.4×	1.1k 0.5×	946	25.2k
Gautam Sethi Singapore	125	26.2k 1.5×	8.7k 1.5×	9.1k 2.1×	4.2k 1.4×	1.5k 0.6×	615	48.2k
Fazlul H. Sarkar United States	100	18.9k 1.1×	9.9k 1.8×	9.0k 2.0×	4.0k 1.3×	1.1k 0.5×	466	33.7k
Adriana Albini Italy	81	10.2k 0.6×	7.0k 1.2×	4.6k 1.0×	2.0k 0.6×	1.4k 0.6×	396	22.9k
Rajesh Agarwal United States	82	10.5k 0.6×	2.4k 0.4×	2.4k 0.6×	1.8k 0.6×	925 0.4×	393	20.4k
Peter J. Houghton United States	86	15.6k 0.9×	7.5k 1.3×	3.2k 0.7×	2.0k 0.7×	1.2k 0.5×	571	28.8k

Countries citing papers authored by Zigang Dong

Since Specialization

Citations

This map shows the geographic impact of Zigang Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zigang Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zigang Dong more than expected).

Fields of papers citing papers by Zigang Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zigang Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zigang Dong. The network helps show where Zigang Dong may publish in the future.

Co-authorship network of co-authors of Zigang Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Zigang Dong. A scholar is included among the top collaborators of Zigang Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zigang Dong. Zigang Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jia, Xuechao, Chuntian Huang, Fangfang Liu, Zigang Dong, & Kangdong Liu. (2024). Elongation factor 2 in cancer: a promising therapeutic target in protein translation. Cellular & Molecular Biology Letters. 29(1). 156–156. 1 indexed citations

Roh, Eunmiri, Jong‐Eun Kim, Tianshun Zhang, et al.. (2023). Orobol, 3′-hydroxy-genistein, suppresses the development and regrowth of cutaneous SCC. Biochemical Pharmacology. 209. 115415–115415. 6 indexed citations

Wang, Jing, Dan Cheng, Keke Zhang, et al.. (2023). miR‐132‐3p promotes heat stimulation‐induced esophageal squamous cell carcinoma tumorigenesis by targeting KCNK2. Molecular Carcinogenesis. 62(5). 583–597. 4 indexed citations

Zhao, Simin, Ke Yao, Kangdong Liu, et al.. (2021). Bestatin Cream Impairs Solar Simulated Light‒Driven Skin Inflammation and Skin Carcinogenesis in Mice. Journal of Investigative Dermatology. 141(11). 2699–2709.e2. 5 indexed citations

Lee, Kun Y., Ke Yao, Seung Ho Shin, et al.. (2020). GSK3β-Mediated Expression of CUG-Translated WT1 Is Critical for Tumor Progression. Cancer Research. 81(4). 945–955. 7 indexed citations

Zhang, Tianshun, Ruihua Bai, Qiushi Wang, et al.. (2019). Fluvastatin Inhibits HMG-CoA Reductase and Prevents Non–Small Cell Lung Carcinogenesis. Cancer Prevention Research. 12(12). 837–848. 24 indexed citations

Bai, Fang, Kangdong Liu, Hui‐Liang Li, et al.. (2017). Veratramine modulates AP-1-dependent gene transcription by directly binding to programmable DNA. Nucleic Acids Research. 46(2). 546–557. 23 indexed citations

Dickinson, Sally E., Karen Blohm‐Mangone, Erik R. Olson, et al.. (2016). Inhibition of Akt Enhances the Chemopreventive Effects of Topical Rapamycin in Mouse Skin. Cancer Prevention Research. 9(3). 215–224. 16 indexed citations

Yu, Siwang, Chung S. Yang, Junyao Li, et al.. (2015). Cancer Prevention Research in China. Cancer Prevention Research. 8(8). 662–674. 25 indexed citations

10.

Lim, Do Young, Mee‐Hyun Lee, Seung Ho Shin, et al.. (2014). (+)-2-(1-Hydroxyl-4-Oxocyclohexyl) Ethyl Caffeate Suppresses Solar UV-Induced Skin Carcinogenesis by Targeting PI3K, ERK1/2, and p38. Cancer Prevention Research. 7(8). 856–865. 7 indexed citations

11.

Yao, Ke, Hanyong Chen, Kangdong Liu, et al.. (2014). Kaempferol Targets RSK2 and MSK1 to Suppress UV Radiation-Induced Skin Cancer. Cancer Prevention Research. 7(9). 958–967. 58 indexed citations

12.

Song, Nu Ry, Eun-Jung Lee, Sanguine Byun, et al.. (2013). Isoangustone A, A Novel Licorice Compound, Inhibits Cell Proliferation by Targeting PI3K, MKK4, and MKK7 in Human Melanoma. Cancer Prevention Research. 6(12). 1293–1303. 24 indexed citations

13.

Byun, Sanguine, Sungyoung Lee, Ji‐Hoon Lee, et al.. (2013). USP8 Is a Novel Target for Overcoming Gefitinib Resistance in Lung Cancer. Clinical Cancer Research. 19(14). 3894–3904. 110 indexed citations

14.

Kim, Mi-Sung, Jong‐Eun Kim, Do Young Lim, et al.. (2013). Naproxen Induces Cell-Cycle Arrest and Apoptosis in Human Urinary Bladder Cancer Cell Lines and Chemically Induced Cancers by Targeting PI3K. Cancer Prevention Research. 7(2). 236–245. 69 indexed citations

15.

Li, Wei, Cong Peng, Mee‐Hyun Lee, et al.. (2013). TRAF4 Is a Critical Molecule for Akt Activation in Lung Cancer. Cancer Research. 73(23). 6938–6950. 91 indexed citations

16.

Lee, Sungyoung, Tae‐Gyu Lim, Hanyong Chen, et al.. (2013). Esculetin Suppresses Proliferation of Human Colon Cancer Cells by Directly Targeting β-Catenin. Cancer Prevention Research. 6(12). 1356–1364. 62 indexed citations

17.

Kim, Dong Joon, Yan Li, Kanamata Reddy, et al.. (2012). Novel TOPK Inhibitor HI-TOPK-032 Effectively Suppresses Colon Cancer Growth. Cancer Research. 72(12). 3060–3068. 88 indexed citations

18.

Urusova, Darya V., Jung‐Hyun Shim, Dong Joon Kim, et al.. (2011). Epigallocatechin-gallate Suppresses Tumorigenesis by Directly Targeting Pin1. Cancer Prevention Research. 4(9). 1366–1377. 96 indexed citations

19.

Kim, Dong Joon, Kanamata Reddy, Myoung Ok Kim, et al.. (2011). (3-Chloroacetyl)-indole, a Novel Allosteric AKT Inhibitor, Suppresses Colon Cancer Growth In Vitro and In Vivo. Cancer Prevention Research. 4(11). 1842–1851. 27 indexed citations

20.

Lee, Kyung‐Mi, Ki Won Lee, Ann M. Bode, Hyong Joo Lee, & Zigang Dong. (2009). Tpl2 Is a Key Mediator of Arsenite-Induced Signal Transduction. Cancer Research. 69(20). 8043–8049. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact